Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor

被引:76
|
作者
Miao, Yinglong [1 ,2 ]
Goldfeld, Dahlia Anne [2 ]
Von Moo, Ee [3 ]
Sexton, Patrick M. [3 ]
Christopoulos, Arthur [3 ]
McCammon, J. Andrew [1 ,2 ,4 ]
Valant, Celine [3 ]
机构
[1] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[3] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
基金
美国国家科学基金会; 英国医学研究理事会;
关键词
GPCR; allosteric modulators; ensemble docking; affinity; cooperativity; MOLECULAR-DYNAMICS SIMULATIONS; RELAXED COMPLEX SCHEME; ACETYLCHOLINE-RECEPTORS; DRUG DISCOVERY; INTERNATIONAL UNION; BINDING-SITES; ACTIVATION; TARGETS; CLASSIFICATION; PHARMACOLOGY;
D O I
10.1073/pnas.1612353113
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Design of ligands that provide receptor selectivity has emerged as a new paradigm for drug discovery of G protein-coupled receptors, and may, for certain families of receptors, only be achieved via identification of chemically diverse allosteric modulators. Here, the extracellular vestibule of the M-2 muscarinic acetylcholine receptor (mAChR) is targeted for structure-based design of allosteric modulators. Accelerated molecular dynamics (aMD) simulations were performed to construct structural ensembles that account for the receptor flexibility. Compounds obtained from the National Cancer Institute (NCI) were docked to the receptor ensembles. Retrospective docking of known ligands showed that combining aMD simulations with Glide induced fit docking (IFD) provided much-improved enrichment factors, compared with the Glide virtual screening workflow. Glide IFD was thus applied in receptor ensemble docking, and 38 top-ranked NCI compounds were selected for experimental testing. In [H-3]N-methylscopolamine radioligand dissociation assays, approximately half of the 38 lead compounds altered the radioligand dissociation rate, a hallmark of allosteric behavior. In further competition binding experiments, we identified 12 compounds with affinity of <= 30 mu M. With final functional experiments on six selected compounds, we confirmed four of them as new negative allosteric modulators (NAMs) and one as positive allosteric modulator of agonist-mediated response at the M-2 mAChR. Two of the NAMs showed subtype selectivity without significant effect at the M-1 and M-3 mAChRs. This study demonstrates an unprecedented successful structure-based approach to identify chemically diverse and selective GPCR allosteric modulators with outstanding potential for further structure-activity relationship studies.
引用
收藏
页码:E5675 / E5684
页数:10
相关论文
共 50 条
  • [41] Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites
    Presland, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (05) : 567 - 576
  • [42] New Metabolite Agonists and Allosteric Modulators for Understudied "Dark" G Protein-Coupled Receptors
    Isom, Daniel
    Kapolka, Nicholas
    Rowe, Jacob
    Taghon, Geoff
    Morgan, Will
    FASEB JOURNAL, 2020, 34
  • [43] Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
    Wang, Liyun
    Martin, Bronwen
    Brenneman, Randall
    Luttrell, Louis M.
    Maudsley, Stuart
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02): : 340 - 348
  • [44] Study sheds light on G protein-coupled receptor allosteric signaling
    Koutsouki, Evgenia
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (18) : 2123 - 2123
  • [45] Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer
    Liu, Junke
    Zhang, Zongyong
    Moreno-Delgado, David
    Dalton, James A. R.
    Rovira, Xavier
    Trapero, Ana
    Goudet, Cyril
    Llebaria, Amadeu
    Giraldo, Jesus
    Yuan, Qilin
    Rondard, Philippe
    Huang, Siluo
    Liu, Jianfeng
    Pin, Jean-Philippe
    ELIFE, 2017, 6
  • [46] Effects of G protein-coupled receptor kinases on desensitization of muscarinic receptors
    Tsuga, H
    Honma, T
    Okuno, E
    Kameyama, K
    Haga, T
    LIFE SCIENCES, 1997, 60 (13-14) : 45 - 45
  • [47] Structure Activity Relationships of Pan-Gαq/11 Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators
    Berizzi, Alice E.
    Bender, Aaron M.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Sexton, Patrick M.
    Langmead, Christopher J.
    Christopoulos, Arthur
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (07): : 1818 - 1828
  • [48] Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGIu5) X-ray Structures
    Christopher, John A.
    Orgovan, Zoltan
    Congreve, Miles
    Dore, Andrew S.
    Errey, James C.
    Marshall, Fiona H.
    Mason, Jonathan S.
    Okrasa, Krzysztof
    Rucktooa, Prakash
    Serrano-Vega, Maria J.
    Ferenczy, Gyorgy G.
    Keseru, Gyorgy M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (01) : 207 - 222
  • [49] Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models
    Cavasotto, Claudio N.
    Palomba, Damian
    CHEMICAL COMMUNICATIONS, 2015, 51 (71) : 13576 - 13594
  • [50] "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu5 Allosteric Ligands
    Hellyer, Shane D.
    Albold, Sabine
    Wang, Taide
    Chen, Amy N. Y.
    May, Lauren T.
    Leach, Katie
    Gregory, Karen J.
    MOLECULAR PHARMACOLOGY, 2018, 93 (05) : 504 - 514